Crossmark Global Holdings Inc. Sells 969 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Crossmark Global Holdings Inc. lowered its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 9.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 9,524 shares of the company’s stock after selling 969 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Bath & Body Works were worth $304,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. First Community Trust NA purchased a new stake in Bath & Body Works in the second quarter worth $30,000. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Bath & Body Works by 65.4% during the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock valued at $72,000 after buying an additional 730 shares during the period. EntryPoint Capital LLC raised its stake in Bath & Body Works by 224.0% in the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock worth $74,000 after buying an additional 1,017 shares in the last quarter. Finally, Abich Financial Wealth Management LLC purchased a new stake in Bath & Body Works in the third quarter worth about $103,000. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Trading Up 0.7 %

Bath & Body Works stock opened at $31.54 on Monday. The firm has a market cap of $6.91 billion, a price-to-earnings ratio of 7.64, a PEG ratio of 1.00 and a beta of 1.79. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a fifty day simple moving average of $30.18 and a two-hundred day simple moving average of $36.38.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.35 by $0.02. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.54%. Bath & Body Works’s dividend payout ratio (DPR) is 19.37%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of research analyst reports. Citigroup reduced their target price on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a report on Tuesday, August 20th. Barclays downgraded Bath & Body Works from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $31.00 to $28.00 in a report on Friday, November 8th. UBS Group reduced their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Robert W. Baird decreased their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Finally, BMO Capital Markets reissued an “outperform” rating and set a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $42.44.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.27% of the stock is currently owned by corporate insiders.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.